Stock listing
KNE Stock Price, News, Filings & Events — Kane Biotech Inc.
Selected listing: KNE · TSXV · CAD · CA
This page tracks Kane Biotech Inc.'s KNE:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:TSXV. KNE:TSXV is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.

- Ticker
- KNE:TSXV
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- TSXV
- Currency
- CAD
Kane Biotech Inc. KNE:TSXV stock context
This page tracks Kane Biotech Inc.'s KNE:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:TSXV. KNE:TSXV is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.
Latest news from Kane Biotech Inc.
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
August 25, 2026
Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
July 2, 2026
Kane Biotech Announces Grant of Stock Options
May 29, 2026
Kane Biotech Announces First Quarter 2026 Financial Results
May 28, 2026
Research Kane Biotech Inc.
Kane Biotech Inc. investor report
Review AI stock analysis and investor report context for KNE:TSXV.
Kane Biotech Inc. company profile
View the public company page for Kane Biotech Inc. on 6ix.
Kane Biotech Inc. news
Read company news and market updates connected to Kane Biotech Inc..
Kane Biotech Inc. investor events
Find investor webinars, events, and replay context for Kane Biotech Inc..